Arun Das - 05 Jan 2022 Form 3 Insider Report for Cabaletta Bio, Inc. (CABA)

Role
Chief Business Officer
Signature
/s/ Arun Das
Issuer symbol
CABA
Transactions as of
05 Jan 2022
Net transactions value
$0
Form type
3
Filing time
13 Jan 2022, 15:34:11 UTC
Next filing
19 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CABA Stock Option (Right to Buy) 05 Jan 2022 Common Stock 29,168 $1.01 Direct F1
holding CABA Stock Option (Right to Buy) 05 Jan 2022 Common Stock 18,416 $11.00 Direct F2
holding CABA Stock Option (Right to Buy) 05 Jan 2022 Common Stock 35,000 $11.47 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 21,529 shares underlying this option have vested and the remainder shall vest in substantially equal monthly installments from January 16, 2022 to November 16, 2022, subject to the reporting person's continued service on each such vesting date.
F2 25% of the shares underlying this option vested and became exercisable on October 24, 2020, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.
F3 25% of the shares underlying this option shall vest and become exercisable on March 1, 2022, with the remainder vesting in twelve substantially equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney